Wasdell gets HPRA nod at its new EU headquarters

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/JoeGough)
(Image: Getty/JoeGough)

Related tags: Wasdell, Ireland, Brexit, HPRA

The Wasdell Group’s new EU headquarters in Dundalk, Ireland is set to commence operations later this year as part of the company’s “proactive contingency plan” ahead of Brexit.

The Health Products Regulatory Authority (HPRA) in December 2018 inspected the Dundalk, Ireland-based facility and has since certified the company to conduct Qualified Person (QP) batch certification and release of pharmaceutical products to Europe.

The facility – following a €30m ($34m) investment in 2018​ – is expected to commence operations in spring 2019, ahead of which the company is launching a recruitment drive for several positions.

A range of services will be offered at the facility, including QP release, analytical testing, and distribution services.

Colin Newbould, director of regulatory affairs and QP services at Wasdell called the Dundalk facility an integral part of the company’s “proactive contingency plan”​ to secure the supply chain ahead of the UK’s exit from the European Union (EU) on March 29, 2019.

CEO Vincent Dunne said in a press release: “With almost 75% of our turnover being a result of export business and a growing customer base in both the Irish and US markets, Dundalk was a logical choice for our EU headquarters.

“The new facility will allow us to continue to act as a gateway to Europe for our British and North American customers.”

The company last year also invested​ £500K ($651.9K) into its new microbiological and analytical laboratory at its Newcastle, UK site. 

Related news

Show more

Related products

show more

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Related suppliers

Follow us


View more